Original Research
Published on 08 Oct 2020
The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study
in Cancer Immunity and Immunotherapy

- 3,607 views
- 7 citations
Original Research
Published on 08 Oct 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 08 Oct 2020
in Microbial Immunology

Original Research
Published on 08 Oct 2020
in Multiple Sclerosis and Neuroimmunology

Mini Review
Published on 08 Oct 2020
in Microbial Immunology

Systematic Review
Published on 08 Oct 2020
in Molecular Innate Immunity

Systematic Review
Published on 08 Oct 2020
in Microbial Immunology

Original Research
Published on 08 Oct 2020
in Immunological Tolerance and Regulation

Opinion
Published on 08 Oct 2020
in Microbial Immunology

Review
Published on 08 Oct 2020
in Molecular Innate Immunity

Original Research
Published on 08 Oct 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 08 Oct 2020
in Microbial Immunology

Mini Review
Published on 08 Oct 2020
in Inflammation

Original Research
Published on 08 Oct 2020
in Molecular Innate Immunity

Original Research
Published on 08 Oct 2020
in Nutritional Immunology

Editorial
Published on 08 Oct 2020
in Vaccines and Molecular Therapeutics
Review
Published on 08 Oct 2020
in Inflammation
